INS and early-onset autosomal dominant Alzheimer disease: Beneficial effects of intranasal insulin administration have been shown in clinical trials of its use to improve memory and cognition, and to reduce the memory loss caused by Alzheimer’s disease and diabetes (Kern et al., 1999; Benedict et al., 2008; Reger et al., 2008).